VEGFA and age-related macular degeneration: In particular, since anti-vascular endothelial growth factor (VEGF) treatment for age-related macular degeneration requires repeated intraocular injections, there are many active investigations to develop a sustained anti-VEGF drug delivery platform with a single injection in order to minimize the need for repeated intraocular injections31.